Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03402126 · ClinicalTrials.gov registry record
Tachy Prediction Download Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 138
- Enrollment target
NCT03402126 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 138 participants.
The verdict
NCT03402126 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
The purpose of the Medtronic Tachy Prediction Download (TPD) study is to collect data from an implantable cardiac defibrillator (ICD) device that will be used to identify markers for imminent onset of ventricular arrhythmias.
Interventions
- OTHER TPD RAMWare
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2018-01-12 |
| Est. Completion | 2020-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03402126
The ClinicalTrials.gov registry entry for NCT03402126 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TPD RAMWare is the first listed.
NCT03402126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03402126 about?
NCT03402126 is a clinical study titled "Tachy Prediction Download Study". The purpose of the Medtronic Tachy Prediction Download (TPD) study is to collect data from an implantable cardiac defibrillator (ICD) device that will be used to identify markers for imminent onset of ventricular arrhythmias.
What is the current status of trial NCT03402126?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2018-01-12. Estimated completion is 2020-02-26.
What interventions are being tested in trial NCT03402126?
The interventions under investigation include: TPD RAMWare (OTHER).
Who is sponsoring clinical trial NCT03402126?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.